| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.8M | +312.4% |
| Cost of Revenue | $7.3M | +313.4% |
| Gross Profit | $4.5M | +310.9% |
| R&D Expense | $123.4M | +32.5% |
| SG&A Expense | $63.1M | +39.4% |
| Operating Income | -$230.0M | — |
| Pre-tax Income | -$141.6M | -38.1% |
| Income Tax | $0 | — |
| Net Income | -$25.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $217.7M | — |
| Short-term Investments | $50.0M | — |
| Accounts Receivable | $11.2M | +131.7% |
| Current Assets | $284.4M | — |
| Total Assets | $348.6M | +49.4% |
| Current Liabilities | $38.6M | — |
| Total Liabilities | $71.5M | +90.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$148.6M | — |
| Capital Expenditures | $2.3M | +19.5% |
| Investing Cash Flow | -$52.3M | -2580.9% |
| Financing Cash Flow | $368.1M | — |
| Free Cash Flow | -$150.9M | -5199.5% |
| -909.1% |
| EPS (Basic) | -$0.51 | — |
| EPS (Diluted) | -$0.51 | — |
| Stockholders' Equity |
| $114.7M |
| +414.7% |